Towards biomarker-driven cancer immunotherapy: the rising of a protein phosphatase regulator
Crossref DOI link: https://doi.org/10.1038/s41392-025-02425-2
Published Online: 2025-10-14
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Xiaoyu
Yang, Weiqin
Cheng, Alfred Sze-Lok
Text and Data Mining valid from 2025-10-14
Version of Record valid from 2025-10-14
Article History
Received: 31 July 2025
Revised: 28 August 2025
Accepted: 4 September 2025
First Online: 14 October 2025
Competing interests
: The authors declare no competing interests.